Five year clinical follow-up of the PASSION-trial Five year clinical follow-up of the PASSION-trial Five Year Follow-up after Primary PCI with a Paclitaxel-Eluting.
The SOS (Stenting Of Saphenous vein grafts) Randomized, Controlled Trial of a Paclitaxel-Eluting Stent Vs. a Similar Bare Metal Stent in Saphenous Vein.
Bruno Dente, Politecnico di Milano Aalborg, 14.06.12 INSTITUTIONAL CAPACITY FOR TERRITORIAL DEVELOPMENT.
Copyleft Clinical Trial Results. You Must Redistribute Slides PEPCAD II ISR Study Paclitaxel-eluting devices: randomized comparison of the SeQuent™ please.
Zinc exhibits ideal physiological corrosion behavior for bioabsorbable stents (Bowen et al., Advanced Materials, 2013)
ARMOUR
EuroPCR 2011 research highlights: A slideshow presentation
Transcatheter Aortic Valve Replacement for Degnerative Bioprosthetic Surgical Valves
Technical approach PCI in Small Vessels Washington Cardiology Center Augusto Pichard, L. Satler, K. Kent, R. Waksman, J. Laird, W. Suddath, J. Sharretts,
Richard Melsheimer Director, Medical Affairs Europe Centocor Eli Lilly and Company Coordinated Use of ReoPro and Drug Eluting Stents: Rationale and Evidence.
FRONTIER Registry The Guidant MULTI-LINK FRONTIER ™ Coronary Stent System for the Treatment of Pts with Native De Novo or Restenotic Bifurcation Coronary.
TAVR. Global and US Data. A.Pichard, L. Satler, R Waksman, I Ben-Dor, N Bernardo, P Corso, S Boyce, S Goldstein, H Cooper, Z Wang, F Asch, J Weidel, T.
